Estimating the efficacy of symptom-based screening for COVID-19

There is substantial interest in using presenting symptoms to prioritize testing for COVID-19 and establish symptom-based surveillance. However, little is currently known about the specificity of COVID-19 symptoms. To assess the feasibility of symptom-based screening for COVID-19, we used data from tests for common respiratory viruses and SARS-CoV-2 in our health system to measure the ability to correctly classify virus test results based on presenting symptoms. Based on these results, symptom-based screening may not be an effective strategy to identify individuals who should be tested for SARS-CoV-2 infection or to obtain a leading indicator of new COVID-19 cases.

[1]  Olivier Bodenreider,et al.  Aggregating UMLS Semantic Types for Reducing Conceptual Complexity , 2001, MedInfo.

[2]  D. Simel,et al.  Does This Patient Have Influenza? , 2006, Annals of Emergency Medicine.

[3]  P. Van Royen,et al.  Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: a cross sectional study , 2011, BMC family practice.

[4]  H. Kelly,et al.  Clinical Predictors of Influenza in Young Children: The Limitations of “Influenza-Like Illness” , 2011, Journal of the Pediatric Infectious Diseases Society.

[5]  H. Goossens,et al.  Validity of a clinical model to predict influenza in patients presenting with symptoms of lower respiratory tract infection in primary care. , 2015, Family practice.

[6]  George Hripcsak,et al.  Parameterizing time in electronic health record studies , 2015, J. Am. Medical Informatics Assoc..

[7]  Christopher Ré,et al.  Medical device surveillance with electronic health records , 2019, npj Digital Medicine.

[8]  P. Godoy,et al.  Usefulness of Clinical Definitions of Influenza for Public Health Surveillance Purposes , 2020, Viruses.

[9]  Melinda Huntington-Frazier,et al.  Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington. , 2020, JAMA.

[10]  Denisa Bojkova,et al.  Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China , 2020, The New England journal of medicine.

[11]  Riley O. Mummah,et al.  Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19 , 2020, eLife.

[12]  N. Shah,et al.  Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. , 2020, JAMA.

[13]  E. Pham,et al.  High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California , 2020, Gastroenterology.

[14]  Akihide Ryo,et al.  Interpreting Diagnostic Tests for SARS-CoV-2. , 2020, JAMA.

[15]  G. Fabbrocini,et al.  Varicella-like exanthem as a specific COVID-19–associated skin manifestation: Multicenter case series of 22 patients , 2020, Journal of the American Academy of Dermatology.